A Giant Silence - An atypical association of sensorineural hearing loss with Giant Cell Arteritis.
clinical aspects
disease etiology and pathogenesis
giant cell arteritis
sensorineural hearing loss
vasculitides
Journal
International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
revised:
04
07
2022
received:
15
06
2022
accepted:
11
07
2022
pubmed:
27
7
2022
medline:
5
10
2022
entrez:
26
7
2022
Statut:
ppublish
Résumé
Giant cell arteritis (GCA) is a chronic vasculitic disorder predominantly affecting medium to large sized arteries, prevalent in the 50 plus age group. This case illustrates an atypical presentation of this disease in the form of bilateral sensorineural hearing loss (SNHL). Apart from the presence of constitutional and vertiginous symptoms, there were essentially no classical features of GCA. Differentials were broad including infection, malignancy and medication toxicity as well as brain, eye and ear syndromes such as Cogan's syndrome, all of which were eventually excluded. Her diagnosis was ultimately confirmed on positron emission tomography, which highlights the diagnostic importance of this modality. She was managed with corticosteroids then tocilizumab and is making a gradual recovery. Literature review demonstrates that SNHL is more prevalent than previously suggested in GCA, although this does not have widespread recognition. Mechanisms of SNHL in GCA include vascular occlusion, immunological mechanisms including cross reactivity with viral antigens and direct viral infection. SNHL does appear to improve with corticosteroids. This case emphasizes the importance of considering GCA as an important differential in SNHL.
Identifiants
pubmed: 35880512
doi: 10.1111/1756-185X.14401
pmc: PMC9796047
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Antigens, Viral
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1203-1207Informations de copyright
© 2022 The Authors. International Journal of Rheumatic Diseases published by Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Références
Int J Rheum Dis. 2022 Oct;25(10):1203-1207
pubmed: 35880512
Medicine (Baltimore). 2019 Apr;98(17):e15286
pubmed: 31027087
Arthritis Rheum. 1999 May;42(5):844-53
pubmed: 10323439
Arthritis Care Res (Hoboken). 2021 Aug;73(8):1071-1087
pubmed: 34235871
BMC Rheumatol. 2017 Nov 28;1:2
pubmed: 30886946
Ann Rheum Dis. 2010 Apr;69(4):780-1
pubmed: 19854712
Ann Otol Rhinol Laryngol. 1980 May-Jun;89(3 Pt 1):215-9
pubmed: 7416666
Ann Otol Rhinol Laryngol. 2002 Nov;111(11):989-97
pubmed: 12450172
JAMA Otolaryngol Head Neck Surg. 2022 Apr 01;148(4):307-315
pubmed: 35201274
Arthritis Res Ther. 2021 Jan 7;23(1):14
pubmed: 33413605
Scand J Rheumatol. 1978;7(3):154-8
pubmed: 725550
Am J Case Rep. 2017 Nov 22;18:1233-1237
pubmed: 29186088
Arthritis Rheum. 1989 Jul;32(7):884-93
pubmed: 2787641
Postgrad Med J. 1982 Jun;58(680):357-8
pubmed: 7122370
Ann Indian Acad Neurol. 2008 Jul;11(3):185-9
pubmed: 19893667
Clin Rheumatol. 2019 Dec;38(12):3655-3660
pubmed: 31420810
Int J Audiol. 2022 May 5;:1-5
pubmed: 35510657
Cureus. 2021 Aug 25;13(8):e17435
pubmed: 34589343
Nat Rev Rheumatol. 2017 Oct;13(10):578-592
pubmed: 28905861
Cureus. 2022 Jan 3;14(1):e20906
pubmed: 35145810
Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii5-iii16
pubmed: 32348512
Thromb J. 2015 Apr 16;13:15
pubmed: 25883536